Youngdoe Kim

404 total citations
23 papers, 226 citations indexed

About

Youngdoe Kim is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, Youngdoe Kim has authored 23 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Genetics and 8 papers in Immunology. Recurrent topics in Youngdoe Kim's work include Inflammatory Bowel Disease (9 papers), Microscopic Colitis (8 papers) and Dermatology and Skin Diseases (5 papers). Youngdoe Kim is often cited by papers focused on Inflammatory Bowel Disease (9 papers), Microscopic Colitis (8 papers) and Dermatology and Skin Diseases (5 papers). Youngdoe Kim collaborates with scholars based in South Korea, Belgium and United States. Youngdoe Kim's co-authors include Rainard Fuhr, Donghoon Shin, Yoo Seok Kim, Yoon Jung Lee, Jung Won Kang, Xavier Pivot, Elsa Curtit, Sungho Won, Bong-Jo Kim and Byong Duk Ye and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and BioMed Research International.

In The Last Decade

Youngdoe Kim

18 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youngdoe Kim South Korea 9 148 53 51 50 43 23 226
Alex Kudrin South Korea 10 215 1.5× 18 0.3× 27 0.5× 41 0.8× 32 0.7× 14 309
Ena Singh United States 7 235 1.6× 42 0.8× 47 0.9× 65 1.3× 74 1.7× 7 323
Jolanta Węgłowska Poland 6 336 2.3× 22 0.4× 27 0.5× 109 2.2× 77 1.8× 16 437
Heike Woehling Germany 9 300 2.0× 10 0.2× 34 0.7× 140 2.8× 102 2.4× 16 377
Q. Li United States 6 318 2.1× 11 0.2× 12 0.2× 13 0.3× 39 0.9× 20 367
A Lanzon Chile 2 186 1.3× 24 0.5× 30 0.6× 73 1.5× 64 1.5× 2 209
Riccardo Pellicano Italy 10 58 0.4× 38 0.7× 6 0.1× 15 0.3× 84 2.0× 15 293
Johann Poetzl United Kingdom 8 299 2.0× 4 0.1× 46 0.9× 128 2.6× 112 2.6× 15 337
Lidija Kandolf Sekulović Serbia 8 63 0.4× 10 0.2× 19 0.4× 5 0.1× 21 0.5× 45 296
Núria Padullés Zamora Spain 9 39 0.3× 62 1.2× 11 0.2× 20 0.4× 13 0.3× 29 156

Countries citing papers authored by Youngdoe Kim

Since Specialization
Citations

This map shows the geographic impact of Youngdoe Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youngdoe Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youngdoe Kim more than expected).

Fields of papers citing papers by Youngdoe Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youngdoe Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youngdoe Kim. The network helps show where Youngdoe Kim may publish in the future.

Co-authorship network of co-authors of Youngdoe Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Youngdoe Kim. A scholar is included among the top collaborators of Youngdoe Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youngdoe Kim. Youngdoe Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jo, Seong Jin, Byung‐Soo Kim, Dong Hyun Kim, et al.. (2025). Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study. The Journal of Dermatology. 52(5). 802–811.
2.
Jeong, Seung‐hwan, Youngdoe Kim, Jae Young Joung, et al.. (2025). A Prospective, Multicenter Study on the Clinical Effectiveness and Safety of Abiraterone Plus Prednisone in Metastatic Hormone-Sensitive Prostate Cancer in Korea: Real-World Data Analysis. SHILAP Revista de lepidopterología. 23(2). 119–125.
3.
4.
Kim, Ji Won, Jun Lee, Joo Sung Kim, et al.. (2024). Effectiveness of Early Thiopurine Use in Korean Patients With Moderate-to-Severe Ulcerative Colitis. Journal of Clinical Gastroenterology. 59(8). 765–772.
5.
6.
Lee, Chang Kyun, Won Moon, Jaeyoung Chun, et al.. (2024). One-year Safety and Effectiveness of Ustekinumab in Patients With Crohn’s Disease: The K-STAR Study. Inflammatory Bowel Diseases. 31(5). 1306–1316. 1 indexed citations
7.
Yoon, Hyuk, Young Soo Park, Jeong Eun Shin, et al.. (2023). Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis: results from the MOSAIK cohort in Korea. BMC Gastroenterology. 23(1). 405–405. 1 indexed citations
8.
Son, Sang Wook, Youngdoe Kim, Hyo Hyun Ahn, et al.. (2022). Differences in Clinical Responses to Ustekinumab Treatment among Body Regions: Results from a Real-World Prospective, Observational, and Multi-Center Study in Korea. Annals of Dermatology. 34(1). 14–14. 3 indexed citations
9.
Cheon, Jae Hee, Hyun‐Soo Kim, Dong Soo Han, et al.. (2022). Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN). Gut and Liver. 17(5). 777–785. 6 indexed citations
10.
Park, Soo Jung, Hyung Wook Kim, Yun Jeong Lim, et al.. (2021). Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study. Gut and Liver. 16(5). 764–774. 8 indexed citations
11.
Yoon, Jin Young, Jae Myung, Chang Kyun Lee, et al.. (2021). Early course of newly diagnosed moderate‐to‐severe ulcerative colitis in Korea: Results from a hospital‐based inception cohort study (MOSAIK). Journal of Gastroenterology and Hepatology. 36(8). 2149–2156. 3 indexed citations
12.
Kim, Youngdoe, et al.. (2021). Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea. Rheumatology and Therapy. 8(3). 1393–1404. 3 indexed citations
13.
Youn, Sang Woong, Byung‐Soo Kim, Youngdoe Kim, et al.. (2021). Clinical outcomes in adult patients with plaque psoriasis treated with ustekinumab under real‐world practice in Korea: A prospective, observational, multi‐center, postmarketing surveillance study. The Journal of Dermatology. 48(6). 778–785. 8 indexed citations
14.
Lee, Chang Kyun, Sung Noh Hong, Jong Pil Im, et al.. (2019). Unmet Psychosocial Needs of Patients with Newly Diagnosed Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea. Gut and Liver. 14(4). 459–467. 17 indexed citations
15.
Pivot, Xavier, Elsa Curtit, Yoon Jung Lee, et al.. (2016). A Randomized Phase I Pharmacokinetic Study Comparing Biosimilar Candidate SB3 and Trastuzumab in Healthy Male Subjects. Clinical Therapeutics. 38(7). 1665–1673.e3. 33 indexed citations
16.
Youn, Sang Woong, Bo Ri Kim, Youngdoe Kim, et al.. (2016). Clinical factors predicting the therapeutic response to ustekinumab in patients with moderate to severe chronic plaque psoriasis. The Journal of Dermatology. 44(5). 560–566. 11 indexed citations
17.
Lee, Yoon Jung, et al.. (2016). A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects. British Journal of Clinical Pharmacology. 82(1). 64–73. 46 indexed citations
18.
Shin, Donghoon, et al.. (2015). A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and Infliximab Reference Product (Remicade®) in Healthy Subjects. BioDrugs. 29(6). 381–388. 55 indexed citations
19.
Kim, Youngdoe, Young Lee, Sungyoung Lee, et al.. (2015). On the Estimation of Heritability with Family-Based and Population-Based Samples. BioMed Research International. 2015. 1–9. 15 indexed citations
20.
Kim, Yun Kyoung, Youngdoe Kim, Mi Yeong Hwang, et al.. (2014). Identification of a genetic variant at 2q12.1 associated with blood pressure in East-Asians by genome-wide scan including gene-environment interactions. BMC Medical Genetics. 15(1). 65–65. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alex Kudrin Breakdown of academic impact, for papers by Ena Singh Breakdown of academic impact, for papers by Jolanta Węgłowska Breakdown of academic impact, for papers by Heike Woehling Breakdown of academic impact, for papers by Q. Li Breakdown of academic impact, for papers by A Lanzon Breakdown of academic impact, for papers by Riccardo Pellicano Breakdown of academic impact, for papers by Johann Poetzl Breakdown of academic impact, for papers by Lidija Kandolf Sekulović Breakdown of academic impact, for papers by Núria Padullés Zamora
Rankless by CCL
2026